KRAS Inhibitors

KRAS is one of the earliest discovered driver genes in cancer, with frequent mutations observed in lung, pancreatic, and colorectal cancers. Mutations in KRAS (such as G12C, G12D) lead to its continuous activation, driving uncontrolled cell proliferation, making it a key therapeutic target. Despite its discovery in the 1980s, KRAS was long considered "undruggable" due to the lack of a suitable binding site. In 2013, researchers discovered that the KRAS G12C mutation forms a "switch-II" pocket that can be targeted by covalent inhibitors, paving the way for KRAS-targeted drug development. Amgen and Mirati developed Sotorasib (Lumakras) and Adagrasib (Krazati), which were approved in 2021 and 2022, marking a new era in KRAS-targeted therapy. As research advances, drug development is expanding to target more challenging KRAS mutations like G12D, combining other therapeutic mechanisms (such as SHP2, EGFR inhibitors, or immunotherapy) to improve efficacy. For example, the novel drug RMC-6236 induces the formation of complexes between CypA and various RAS(ON) mutant proteins, inhibiting tumor growth and offering an innovative treatment approach. The development of KRAS-targeted drugs breaks the "undruggable" barrier, signaling a paradigm shift towards precision therapy. AMbeed offers a range of KRAS inhibitors, especially milestone novel KRAS inhibitors, to meet your research needs.

KRAS Inhibitors

MRTX849 acid
click to sign in and save

A15501052561529-96-098%

MRTX849 acid

$370.00/1mg Detail

KRAS G12D inhibitor 3 TFA
click to sign in and save

A16014662757095-12-698%

KRAS G12D inhibitor 3 TFA

$224.00/1mg Detail

(R)-BI-2852
click to sign in and save

A16405772375482-49-695%

(R)-BI-2852

$342.00/10mg Detail

KRAS G12D inhibitor 17
click to sign in and save

A17030442821793-99-998%

KRAS G12D inhibitor 17

$672.00/1mg Detail

SOS1-IN-14
click to sign in and save

A17028632793405-20-498%

SOS1-IN-14

$273.00/1mg Detail

SOS1-IN-15
click to sign in and save

A17277372793404-47-298%

SOS1-IN-15

$368.00/5mg Detail

Fulzerasib
click to sign in and save

A19380042641747-54-699%

Fulzerasib

$109.00/1mg Detail

SAH-SOS1A TFA
click to sign in and save

A20217022896737-31-698%

SAH-SOS1A TFA

$246.00/5mg Detail

TH-Z835
click to sign in and save

A22882262766209-50-998%

TH-Z835

$323.00/1mg Detail

pan-KRAS-IN-2
click to sign in and save

A23184222882825-14-998%

pan-KRAS-IN-2

$294.00/1mg Detail

Spiclomazine
click to sign in and save

A62160024527-27-398%

Spiclomazine

$112.00/5mg Detail

Deltarasin
click to sign in and save

A2147771440898-61-296%

Deltarasin

$151.00/5mg Detail

K-Ras G12C-IN-1
click to sign in and save

A7983551629265-17-398+%

K-Ras G12C-IN-1

$392.00/5mg Detail

6H05 TFA
click to sign in and save

A6305542061344-88-395%

6H05 TFA

$129.00/5mg Detail

1 2 3 4    page 4 of 4 Pages